We’re pleased to participate in the private company track of the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, where our CEO Peter Lawrence will discuss Cardurion's progress in a fireside chat at 11:30 AM today.
Cardurion Pharmaceuticals
Biotechnology Research
Burlington, Massachusetts 2,956 followers
Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics
About us
Cardurion Pharmaceuticals is a next generation cardiovascular company focused on the discovery and development of novel therapeutics for the treatment of heart failure and other cardiovascular diseases. Led by an experienced team of CV experts and industry veterans, we are developing groundbreaking clinical programs in PDE9 and CaMKII inhibition. We take a strategic portfolio approach driven by in-house drug discovery and our office of strategy and have concluded foundational partnerships with key strategics and investors, including an up to $300 million dollar investment from Bain Capital to support current programs and pipeline growth. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan. For more information, please visit the company’s website at http://www.cardurion.com.
- Website
-
http://www.cardurion.com
External link for Cardurion Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Burlington, Massachusetts
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Biotechnology, Therapeutics, Cardiovascular, Heart Failure, and Cardiology
Locations
-
Primary
78 Blanchard Road
Suite 200
Burlington, Massachusetts 01803, US
-
26-1, Muraoka-Higashi 2-chome
Fujisawa, Kanagawa 251-8555, JP
Employees at Cardurion Pharmaceuticals
Updates
-
At the European Society of Cardiology #ESCCongress, we're continuing to present our data showing clinical validation of our PDE9 inhibitor program. We are now excited to have two Phase 2 clinical trials underway with our lead PDE9 inhibitor, CRD‑750, in 640 patients with both types of #heartfailure, HFrEF and HFpEF. #cardiovasculardisease #CVdruginnovation
-
Thank you Nasdaq for recognizing our Series B financing news on the Times Square tower in NYC!
-
Read about our financing news in BioSpace. #heartfailure #cardiovasculardisease #CVdruginnovation https://lnkd.in/e-pvXbmy
-
BioPharma Dive digs into our financing news and our approach to creating new treatments for #cardiovasculardisease. https://lnkd.in/dcfggGar
Cardurion raises another $260M to fuel heart drug pipeline
biopharmadive.com
-
Cardurion is positioned for our next stage of growth, fueled by a strong syndicate of investors and our passionate team of experts in #cardiovasculardisease. We are ready to advance groundbreaking medicines to address unmet needs for patients. #heartfailure #cardiovasculardisease #CVdruginnovation https://lnkd.in/eS8XMqeq
-
We appreciate the strong support of our Series B syndicate, led by Ascenta Capital, and joined by existing investors, Bain Capital Life Sciences and Bain Capital Private Equity, and new investors, NEA, GV, Fidelity Management & Research Company, Millennium Management, Invus, Farallon Capital Management, Blue Owl Healthcare Opportunities, Delos Capital and Digitalis Ventures. #heartfailure #cardiovasculardisease #CVdruginnovation https://lnkd.in/eS8XMqeq
-
Cardurion Pharmaceuticals reposted this
Today we announce a $260M Series B financing, which will support continued progress with our two clinical stage drug candidates and expansion of our #cardiovasculardisease portfolio. https://cardurion.com/ #heartfailure #CVdruginnovation https://lnkd.in/ed-h3Z-s
-
Today we announce a $260M Series B financing, which will support continued progress with our two clinical stage drug candidates and expansion of our #cardiovasculardisease portfolio. https://cardurion.com/ #heartfailure #CVdruginnovation https://lnkd.in/ed-h3Z-s
-
Though #Pride month is coming to a close, Cardurion is always a proud supporter of our LGBTQ+ community, committed to showing up in celebration, solidarity, and reflection. #loveislove #humanrights #inclusion #OneCardurion